Association between Resistant Arterial Hypertension, Type 2 Diabetes, and Selected microRNAs

Robert Błaszczyk,Alicja Petniak,Jacek Bogucki,Janusz Kocki,Andrzej Wysokiński,Andrzej Głowniak
DOI: https://doi.org/10.3390/jcm13020542
IF: 3.9
2024-01-18
Journal of Clinical Medicine
Abstract:Introduction: In recent years, a very close relationship between miRNA and cardiovascular diseases has been found. RAH and T2DM are accompanied by a change in the microRNA expression spectrum. Objectives: This study aimed to evaluate the clinical characteristics and expression of selected microRNAs in patients with idiopathic RAH and T2DM. Patients and methods: A total of 115 patients with RAH were included in this study. Among them were 53 patients (46.09%) with T2DM. miRNA levels were determined using quantitative real-time polymerase chain reaction. The expression of the examined genes was calculated from the formula RQ = 2−ΔΔCT. Results: Analysis using the Mann–Whitney U test showed a statistically significant (p < 0.05) difference in the expression of MIR1-1 (p = 0.031) and MIR195 (p = 0.042) associated with the occurrence of T2DM in the subjects. The value of MIR1-1 gene expression was statistically significantly higher in patients with T2DM (median: 0.352; mean: 0.386; standard deviation: 0.923) compared to patients without T2DM (median: 0.147; mean: −0.02; standard deviation: 0.824). The value of MIR195 gene expression was statistically significantly higher in patients with T2DM (median: 0.389, mean: 0.442; standard deviation: 0.819) compared to patients without T2DM (median: −0.027; mean: 0.08; standard deviation: 0.942). Conclusions: The values of MIR1-1 and MIR195 gene expression were statistically significantly higher in patients with RAH and T2DM compared to patients with RAH and without T2DM. Further studies are necessary to precisely clarify the roles of miRNAs in patients with RAH and T2DM. They should demonstrate the utility of these genetic markers in clinical practice.
medicine, general & internal
What problem does this paper attempt to address?
The paper aims to explore the relationship between Resistant Arterial Hypertension (RAH) and Type 2 Diabetes Mellitus (T2DM), and to evaluate the expression of specific microRNAs (miRNAs) in these two diseases. Specifically, the objectives of the study include: 1. **Evaluation of Clinical Characteristics**: The study included 115 RAH patients, of which 53 (approximately 46.09%) had T2DM. Researchers collected clinical characteristics of these patients, including age, gender, blood pressure control status, etc. 2. **miRNAs Expression Analysis**: Using quantitative real-time polymerase chain reaction (qRT-PCR) technology, the expression levels of specific miRNAs in these patients were detected, including MIR1-1, MIR195, etc. The main findings include: - **Differences in MIR1-1 and MIR195 Expression**: Statistical analysis showed that the gene expression of MIR1-1 and MIR195 was significantly higher in patients with RAH combined with T2DM compared to those with only RAH. - **Trends in Other miRNAs**: The expression of MIR126, MIR133A1, MIR143, and MIR320A in T2DM patients showed a trend towards significance. In summary, this study attempts to explore the role of these miRNAs in the occurrence and development of diseases by analyzing the expression levels of specific miRNAs in RAH and T2DM patients, providing basic data for further research.